Argentina Pharmaceuticals & Healthcare Report Q1 2016 - New Report Available

From: Fast Market Research, Inc.
Published: Wed Nov 11 2015

The improvement in Arg entina's business environment that is expected take place with the next government administration will contribute to increased market attractiveness to pharmaceuticals and healthcare investors. Moreover, a recent agreement aimed at improving access to high value medicines and treatments for rare diseases will greatly improve the appeal of Mercosur countries, including Argentina, to multinational s , posing upside risks to our forecasts. We also highlight that the Argentinean regulatory environment may be positively modified over the next years; including the updating of the intellectual property rights protection system and the eventual introduction of a single payer reimbursem ent model. However, we remain cautious over the ultimate medium-term impact should these reforms be approved, as the government will likely continue to place significant attention on ensuring access to low er cost generic medicines and controlling rising healthcare costs .

Full Report Details at

Headline Expenditure Projections

Pharmaceuticals: ARS54.93bn (USD6.76bn) in 2014 to ARS59.48bn (USD6.57bn) in 2015; +8.3% in local currency terms and -2.8% in US dollar terms. Forecast revised upwards from last quarter .
Healthcare: ARS259.07bn (USD31.89bn) in 2014 to ARS277.69bn (USD30.68bn) in 2015; +7.2% in local currency terms and -3.8% in US dollar terms. Forecast revised downwards from last quarter.

The Argentina Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Argentina Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Argentina pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Argentina, to test other views - a key input for successful budgeting and strategic business planning in the Argentinian pharmaceutical and healthcare market.
* Target business opportunities and risks in the Argentinian pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Argentina.
* Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.


BMI Industry View

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Kenya Pharmaceuticals & Healthcare Report Q1 2016
- Thailand Pharmaceuticals & Healthcare Report Q1 2016
- Pakistan Pharmaceuticals & Healthcare Report Q1 2016
- Croatia Pharmaceuticals & Healthcare Report Q1 2016
- Puerto Rico Pharmaceuticals & Healthcare Report Q1 2016

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »